About Drug and Therapeutics Bulletin

Aims and Scope

For over 50 years, DTB has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB was started in 1962. From the outset, it has provided healthcare professionals with independent, clear, reliable information and advice to help ensure patients get the best care. DTB conclusions represent a synthesis of the best available medical evidence with opinions from a wide range of commentators.

Published monthly by BMJ, DTB is wholly independent of industry, Government and regulatory authorities and does not carry any display advertising or accept any form of commercial sponsorship. DTB provides articles based on a synthesis of evidence with opinions from a wide range of specialist and generalist commentators, typically over 40 individuals and organisations are invited to comment on each article.

Over the years, DTB has initiated successful campaigns for the removal or restriction of medicines that it could not recommend, prompted withdrawal of excessive promotional claims and exposed fundamental weaknesses in certain prescribing practice. Surveys of our readership have consistently shown that readers find DTB authoritative and influential in relation to their decisions, recommendations or advice on treatments. These are just a few of the examples of why DTB is regarded as an indispensable part of evidence-based clinical practice and has been described as both essential reading for practising doctors and as a key information source by the House of Commons Health Select Committee in the UK.


DTB is owned by BMJ.

Journal Statistics

Frequency Monthly
Indexed by Index Medicus (Medline), ISI Current Contents (Web of Science), Excerpta Medica (Embase)
Launch date 1962
ISSN of DTB 0012-6543
ISSN of DTB Online 1755-5248

Contact Information

For all contact information please refer to the Contact Us page.

Rights and Permissions

Copyright and Permissions Guidelines


COPEBMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

Equator The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.

AllTrials logoBMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.

Free sample issue

This DTB issue is free to all users to allow everyone the opportunity to see the full scope and typical content published in the bulletin.

View free sample issue >>

DTB now online first!

Sign up to receive email alerts when new content is published online before it appears in print.